Log In
Print this Print this

PritorPlus 80/25

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionCombination of 80 mg telmisartan angiotensin receptor blocker plus 25 mg hydrochlorothiazide angiotensin-converting enzyme (ACE) inhibitor
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Angiotensin-converting enzyme (ACE)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat uncontrolled hypertension
Regulatory Designation
PartnerBayer AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today